You must be 21+ to access this website.
All materials are designated strictly for laboratory research use only.
Priority access to new compound drops, restock alerts, and fresh COA releases. Single-use code, sent by email.
All materials are designated strictly for laboratory research use only.
| QUANTITY | PRICE / UNIT |
|---|---|
| 2–9 | $82.99 |
| 10–19 | $79.99 |
| 20+BEST VALUE | $76.99 |
Your vials are not empty. The lyophilized material may collect at the bottom of the vial and can appear minimal prior to inspection.
All products are supplied as lyophilized (freeze-dried) powder and require reconstitution. Bacteriostatic water is not supplied.
Store in a dry, cool, and dark environment away from UV exposure. For optimal preservation, storage at approximately 4°C is recommended.
This material is strictly for laboratory and research use only. No instructions regarding reconstitution, dosing, or administration can be provided.
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Kindly review our Terms & Conditions before making a purchase.
This blend contains two research-grade peptides—CJC-1295 (No DAC) and Ipamorelin—combined in a single lyophilized vial for controlled laboratory studies investigating complementary growth hormone-releasing pathways. CJC-1295 (No DAC), a synthetic analog of growth hormone-releasing hormone (GHRH), has been examined in peer-reviewed literature, including mechanistic findings referenced under PubMed ID: 16352683, describing GHRH analog interactions with pituitary receptor signaling. Ipamorelin, a selective pentapeptide ghrelin receptor agonist, is widely used to study growth hormone secretagogue receptor (GHS-R) signaling, receptor selectivity, and somatotroph cell activity.
When used together in mechanistic research models, this combination provides a unique tool for examining multi-pathway interactions involving GHRH receptor binding, GHS-R signaling cascades, cyclic AMP modulation, calcium-mediated signaling, and coordinated somatotroph stimulation. The blend format ensures consistent composition for in-vitro biochemical assays and pathway mapping studies where synergistic peptide activity is of investigative interest.
Your vials are not empty. The lyophilized material may collect at the bottom of the vial and can appear minimal prior to inspection.
All products are supplied as lyophilized (freeze-dried) powder and require reconstitution. Bacteriostatic water is not supplied.
Store in a dry, cool, and dark environment away from UV exposure. For optimal preservation, storage at approximately 4°C is recommended.
This material is strictly for laboratory and research use only. No instructions regarding reconstitution, dosing, or administration can be provided.
| QUANTITY | PRICE / UNIT |
|---|---|
| 2–9 | $82.99 |
| 10–19 | $79.99 |
| 20+BEST VALUE | $76.99 |
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Kindly review our Terms & Conditions before making a purchase.
| Compound Type | Two-peptide blend |
| Peptide Class | Peptide blend (CJC-1295 No DAC + Ipamorelin) |
| CAS Number | None assigned |
| PubChem CID | None assigned |
| Physical Form | Lyophilized powder |
| Storage | Store lyophilized at -20°C; reconstitute and store at 2–8°C |
Purity and identity confirmed per Certificate of Analysis. For laboratory research use only. Not for human or veterinary use.
